Axim Biotechnologies, Inc. (AXIM): Net Income
Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
-$8.06M
Year ended 2023-12-31
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | -$8.06M | n/m | 2024-04-16, From 2023-01-01 |
| 2022-12-31 | -$6.24M | n/m | 2024-04-16, From 2022-01-01 |
| 2021-12-31 | -$16.03M | n/m | 2023-04-17, From 2021-01-01 |
| 2020-12-31 | -$6.41M | n/m | 2022-04-19, From 2020-01-01 |
| 2019-12-31 | -$6.45M | n/m | 2021-04-26, From 2019-01-01 |
| 2018-12-31 | -$6.75M | n/m | 2020-05-20, From 2018-01-01 |
| 2017-12-31 | -$4.17M | n/m | 2019-04-08, From 2017-01-01 |
| 2016-12-31 | -$5.81M | n/m | 2018-03-15, From 2016-01-01 |
| 2015-12-31 | -$10.09M | n/m | 2017-09-14, From 2015-01-01 |
| 2014-12-31 | -$582.9K | n/m | 2016-04-18, From 2014-01-01 |
| 2013-12-31 | -$89.2K | n/m | 2015-04-14, From 2013-01-01 |
| 2012-12-31 | -$14.9K | n/m | 2014-03-04, From 2012-01-01 |
| 2011-12-31 | -$2.8K | n/a | 2013-04-15, From 2011-01-01 |